BVS
Bioventus Inc.
NASDAQ · Healthcare · Medical - Devices · US
$10.95
−16.77%Price chart
Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29Nov 3
Key dataNov 3, 2026
Open$10.97
From 52W high−28.28%
Volume2.44M
Market cap$749.45M
P/E (TTM)12.9x
P/S (TTM)1.3x
Div yield—
Key dataNov 3, 2026
Open
$10.97
From 52W high
−28.28%
Volume
2.44M
Market cap
$749.45M
ValuationView details →
P/E (Fwd)
12.9x
EV/EBITDA
8.6x
P/E (TTM)
12.9x
RSI (14)
28.0
MomentumView details →
1D Return
−16.77%
YTD Return
+44.02%
SummaryUpdated Sep 1, 2026
Bioventus Inc. (NASDAQ:BVS) is a medical device company founded in 2011 and headquartered in Durham, North Carolina. The company went public in February 2021 and focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing processes. Bioventus serves physicians across the orthopedic continuum in various settings including physician offices, ambulatory surgical centers, and hospitals. The company has experienced significant operational challenges in recent years but has been working to stabilize its business and return to profitable growth through strategic divestitures and operational improvements.
Similar companies
Latest newsMore news →